CX 2019 Presentations
Please note: Some presentations may not be available as permission may not have been given to publish. Sometimes this will include a debate session, during which one speaker has given permission but another speaker has denied it, resulting in the entire session not being uploaded to the website.
Venous and Lymphatic Challenges - Tuesday, 16th April
Venue: Lower Main Auditorium
Time: 08:00 - 18:00
Superficial veins
Chairing: | Stephen Black, London, United Kingdom |
Moderator: | Raghu Kolluri, Columbus, United States |
Truncal vein treatment
Time: 08:00 - 08:08
How to choose between endovenous modalities
Speaker: | Armando Mansilha, President EBVS, Porto, Portugal |
Time: 08:08 - 08:16
Foam sclerotherapy can replace phlebectomy for the management of varicosities
Speaker: | Claudine Hamel-Desnos, Caen, France |
Time: 08:16 - 08:24
The benefit of non-thermal modalities
Speaker: | Steve Elias, Englewood, United States |
Time: 08:24 - 08:32
Technique and strategy are as important as modality in the treatment of superficial reflux
Speaker: | Manj Gohel, Cambridge, United Kingdom |
Time: 08:48 - 08:56
Podium 1st: VeClose Extension Study five-year results
Speaker: | Nick Morrison, Scottsdale, United States |
Time: 08:56 - 09:04
Post-procedure care after cyanoacrylate glue closure
Speaker: | Kathleen Gibson, Bellevue, United States |
Time: 09:04 - 09:12
The evolution of superficial venous management has moved away from thermal techniques
Speaker: | Kursat Bozkurt, Istanbul, Turkey |
Time: 09:28 - 09:36
3RF Trial: Randomised trial of three radiofrequency devices for great saphenous vein ablation
Speaker: | Isaac Nyamekye, Worcester, United Kingdom |
Time: 09:36 - 09:44
Current theories on indications and techniques for perforator ablation
Speaker: | Kathleen Gibson, Bellevue, United States |
Coffee and visit to hands-on workshops
Time: 10:00 - 10:30
Coffee Symposium: Arterial and venous insufficiency treatment with RD Global innovative medical devices - Satellite
Time: 10:00 - 10:30
Speaker: | Rasit Dinc, Ankara, Turkey |
Time: 10:00 - 10:05
Thermal ablation for varicose insufficiency with ThermoBlock RF technology
Time: 10:05 - 10:10
Glue ablation innovative technology for varicose insufficiency with Venablock, VeinOff and Internal Compresion Therapy (ICT)
Time: 10:10 - 10:15
Deep vein thrombosis management with Mantis, Dovi Aspiration, Viper and Inca Filter
Time: 10:15 - 10:20
Peripheral artery disease treatment with Temren Atherectomy device and Drug Eluting Balloon
Time: 10:20 - 10:25
Vascular access with RD Global Technology: Jaguar Support Catheter, Microcatheter and Guide Catheter
Advanced venous disease
Time: 10:30 - 10:44
Chairing: | Manj Gohel, Cambridge, United Kingdom |
Moderator: | Kathleen Gibson, Bellevue, United States |
Time: 10:30 - 10:37
Role of elevated central venous pressures in chronic venous insufficiency
Speaker: | Raghu Kolluri, Columbus, United States |
Time: 10:37 - 10:44
Chronic venous hypertension: What to do when there is no venous disease to treat
Speaker: | Sergio Gianesini, Ferrara, Italy |
Lymphoedema
Time: 10:44 - 11:12
Time: 10:44 - 10:51
Optimal lymphoedema diagnosis and management in 2019
Speaker: | Peter Mortimer, London, United Kingdom |
Time: 10:51 - 10:58
A pragmatic approach to the assessment of swollen legs
Speaker: | Sarah Thomis, Leuven, Belgium |
Venous ulceration (iWounds)
Time: 11:12 - 11:54
Time: 11:12 - 11:19
Novel treatments for intractable leg ulcers
Speaker: | Alfred Obermayer, Vienna, Austria |
Time: 11:19 - 11:26
How to maximise implementation and impact post-EVRA
Speaker: | Alun Davies, London, United Kingdom |
Time: 11:26 - 11:33
Optimal assessment and treatment pathways for recalcitrant leg ulcers
Speaker: | Thomas O'Donnell, Boston, United States |
Time: 11:33 - 11:40
Novel wound dressings to meet the challenge of recalcitrant venous ulcers
Speaker: | Keith Harding, Cardiff, United Kingdom |
Pelvic venous disease
Time: 11:54 - 12:30
Time: 11:54 - 12:01
How to decide when pelvic venous reflux is clinically relevant and pelvic congestion syndrome
Speaker: | Neil Khilnani, New York, United States |
Time: 12:01 - 12:15
CX Debate: The dangers of stenting for Nutcracker syndrome far outweigh any benefits
For the motion
Time: 12:01 - 12:08
Gerard O’Sullivan, Galway, Ireland |
Against the motion
Time: 12:08 - 12:15
Olivier Hartung, Marseille, France |
Lunch and visit to hands-on workshops
Time: 12:30 - 13:30
Deep venous system
Time: 13:30 - 15:30
Chairing: | Alun Davies, London, United Kingdom |
Moderator: | Rick de Graaf, Friedrichshafen, Germany |
Chronic venous outflow obstruction/ Acute DVT treatment/ Deep venous reflux
Time: 13:30 - 15:30
Time: 13:30 - 13:38
Optimising pathways for acute DVT treatment
Speaker: | Prakash Saha, London, United Kingdom |
Time: 13:38 - 13:54
CX Debate: Aggressive thrombus removal for iliofemoral DVT is overutilised as most patients do not develop significant PTS
For the motion
Time: 13:38 - 13:46
Manj Gohel, Cambridge, United Kingdom |
Against the motion
Time: 13:46 - 13:54
Michael Lichtenberg, Arnsberg, Germany |
Time: 14:08 - 14:16
Optimal outcomes assessment after acute DVT thrombolysis
Speaker: | Raghu Kolluri, Columbus, United States |
Time: 14:16 - 14:26
CAVA trial
Speaker: | Cees Wittens, Maastricht, Netherlands |
Time: 14:26 - 14:34
Where next after ATTRACT and CAVA
Speaker: | Mitchell Silver, Columbus, United States |
Time: 14:48 - 14:56
Complications and disasters during deep venous stenting procedures
Speaker: | Gerard O’Sullivan, Galway, Ireland |
Time: 14:56 - 15:04
An update on stent trials and the role of IVUS
Speaker: | Erin Murphy, Charlotte, United States |
Time: 15:04 - 15:12
The challenge of inflow - how can we assess it and what to look for
Speaker: | Houman Jalaie, Aachen, Germany |
Time: 15:12 - 15:20
What next when stents fail
Speaker: | Stephen Black, London, United Kingdom |
Tea and visit to hands-on workshops
Time: 15:30 - 16:00
Deep venous disease (continued)
Time: 16:00 - 17:10
Chairing: | Manj Gohel, Cambridge, United Kingdom |
Moderator: | Stephen Black, London, United Kingdom |
Time: 16:00 - 16:07
The challenge of the femoral vein - treating post-thrombotic syndrome with normal iliac outflow
Speaker: | Steve Elias, Englewood, United States |
Time: 16:07 - 16:14
Latest advances with percutaneous deep venous valves
Speaker: | Steven Dubenec, Sydney, Australia |
Time: 16:14 - 16:21
Endovascular rescue strategies for in-stent thrombus lining and occlusion
Speaker: | Erin Murphy, Charlotte, United States |
Time: 16:35 - 16:42
Meeting the challenges of upper limb venous outflow obstruction
Speaker: | Rick de Graaf, Friedrichshafen, Germany |
Time: 16:56 - 17:03
Central vein obstruction - stenting in the SVC and IVC
Speaker: | Narayanan Thulasidasan, London, United Kingdom |
Time: 17:03 - 17:10
Strategies and pitfalls for venous stents for the upper limb
Speaker: | Steven Dubenec, Sidney, Australia |
Miscellaneous venous topics
Time: 17:10 - 18:00
Time: 17:10 - 17:17
Latest advances in managing C1 disease
Speaker: | Paul Pittaluga, Monaco, Monaco |
Time: 17:17 - 17:24
New horizons for venous specialists
Speaker: | Sriram Narayanan, Singapore, Singapore |
Time: 17:24 - 17:31
IVUS in venous interventions - reduction in radiation exposure
Speaker: | Narayan Karunanithy, London, United Kingdom |
Time: 17:31 - 17:38
Where do we stand with IVC filters in 2019
Speaker: | Richard McWilliams, Liverpool, United Kingdom |
Time: 17:38 - 17:45
The current and future role of medical apps in venous care
Speaker: | Oscar Johnson, London, United Kingdom |